Rafael Natanek is a partner in the private equity team of Gilde Healthcare.

He is leading deal origination and deal execution in several healthcare vectors in Europe. He serves on the supervisory board of KLIFO and Acti-Med and he previously was on the board of Symeres.

Besides his investment role, Rafael is responsible for coordinating the fund’s portfolio management activities.

Prior to joining Gilde Healthcare, Rafael was a Partner at Bain & Company in London, where he advised private equity funds on healthcare transactions, and pharmaceutical and medtech companies on strategy, organization and commercial issues.

Prior to Bain, he was with McKinsey & Company. Rafael holds a MSc in Chemical Engineering from Lund Institute of Technology, and a MSc in Biomedicine from Lund University, Sweden. He did his thesis at UC Berkeley, California.